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A B S T R A C T
The inflammasome machinery has recently been recognized as an emerging pillar of innate immunity. However,
little is known regarding the interaction between the classical interferon (IFN) response and inflammasome
activation in response to norovirus infection. We found that murine norovirus (MNV-1) infection induces the
transcription of IL-1β, a hallmark of inflammasome activation, which is further increased by inhibition of IFN
response, but fails to trigger the release of mature IL-1β. Interestingly, pharmacological inflammasome inhibitors
do not affect viral replication, but slightly reverse the inflammasome activator lipopolysaccharide (LPS)-medi-
ated inhibition of MNV replication. LPS efficiently stimulates the transcription of IFN-β through NF-ĸB, which
requires the transcription factors IRF3 and IRF7. This activates downstream antiviral IFN-stimulated genes
(ISGs) via the JAK-STAT pathway. Moreover, inhibition of NF-ĸB and JAK-STAT signaling partially reverse LPS-
mediated anti-MNV activity, suggesting additional antiviral mechanisms activated by NF-ĸB. This study reveals
additional insight in host defense against MNV infection.
1. Introduction
Norovirus is a major cause of epidemic nonbacterial gastroenteritis
worldwide. Currently, no vaccination or specific antiviral treatment is
available except for supportive care and supplementation of fluids,
exerting a great global economic burden and significant impact on
public health (Karst et al., 2014). The lack of a robust human norovirus
(HuNV) cell culture system is a key bottleneck for norovirus research.
Recent studies have achieved some success in culturing HuNV in in-
testinal enteroid or B cells with modest viral replication level (Ettayebi
et al., 2016; Jones et al., 2015), and in zebrafish larvae (Van Dycke
et al., 2019) and human induced pluripotent stem cell-derived in-
testinal epithelial cells (Sato et al., 2019), but these systems have not
been widely used. A HuNV subgenomic replicon model in Huh7 cell line
is widely used, for instance for antiviral drug evaluation (Chang et al.,
2006). Murine norovirus (MNV), permissive for replication in both cell
culture and small-animal models, shares similar structural, biochemical
and genetic features with HuNV, and thus has become a useful model
for studying norovirus biology and associated pathology (Wobus et al.,
2004, 2006).
Innate immune response provides the first line of defense against
viral infection through the recognition of pathogen associated mole-
cular patterns (PAMPs) by its pattern recognition receptors (PRRs)
including the recognized Toll-like receptors (TLRs), NOD-like receptors
(NLRs), RIG-I like receptor (RLRs) and the cyclic GMP-AMP synthase
(cGAS) (Wu and Chen, 2014). During viral replication, the accumulated
nucleic acids within cells can be sensed by certain PRRs, and then ra-
pidly activate the following intracellular transcription factors such as
nuclear factor-ĸB (NF-ĸB) and IFN-regulatory factors (IRF3 and IRF7),
leading to secretion of cytokines and chemokines including IFNs
(Schneider et al., 2014). The released IFNs bind to their receptors on the
cell surface, and in turn activate Janus kinase (JAK)-signal transducer
and activator of transcription (STAT) signaling pathway and further
induce transcription of hundreds of IFN-stimulated genes (ISGs). A
subset of ISGs are ultimate antiviral effectors limiting viral replication
and spread (Schoggins et al., 2011). More recently, the inflammasome
signaling has also been reported to exert a central role in the regulation
of gastrointestinal health and disease (Man, 2018). Inflammasomes are
multiprotein complexes that induce downstream immune responses to
specific pathogens and host cell damage (Chen and Ichinohe, 2015).
Once activated, inflammasomes can induce the activation of caspases
and release of mature interleukin-1β (IL-1β) and IL-18, and execute a
form of inflammatory cell death known as pyroptosis (Chen and
Ichinohe, 2015; Man, 2018).
Lipopolysaccharide (LPS) is an important structural component of
the outer membrane of gram-negative bacteria, acting as a potent
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inflammasome activator. Upon LPS recognition, TLR4 signaling can be
activated by undergoing oligomerization and recruiting its downstream
adaptors through interactions with the TIR (Toll-interleukin-1 receptor)
domains, which further induces the proinflammatory cytokine expres-
sion and IFNs secretion through myeloid differentiation primary re-
sponse gene 88 (MyD88)-dependent or MyD88-independent pathways
(Lu et al., 2008). Moreover, LPS has been reported to associate with
non-canonical inflammasome activation by binding with caspase 11
and then cleaving gasdermin D to induce pyroptotic cell death (Broz
and Dixit, 2016).
Inflammasome activation is essential in controlling viral infection,
such as rotavirus and influenza virus (Ichinohe et al., 2009; Zhu et al.,
2017). Previous studies have reported that MNV-1 was rapidly cleared
in wild-type mice (Karst et al., 2003), but persisted much longer in
NLRP6-deficient mice (Wang et al., 2015), suggesting the potential
involvement of inflammasome activation in norovirus infection. A re-
cent study has revealed that MNV infection induced secretion of mature
IL-1β by activating NLRP3 inflammasome in primary bone marrow-
derived macrophages (BMDMs) that primed with TLR2 agonist, and in
STAT1 deficient BMDMs that without TLR2 priming (Dubois et al.,
2019). In this study, we investigated whether the IFN and inflamma-
some machineries interact and collectively respond to norovirus infec-
tion, and LPS-mediated anti-norovirus response.
2. Materials and methods
2.1. Reagents
Human IFN-α (Thermo Scientific, the Netherlands) and mouse IFN-γ
(ab9922, Abcam) were dissolved in PBS. Lipopolysaccharide (LPS;
L6529, Sigma) and adenosine 5-triphosphate disodium salt hydrate
(ATP; A3377, Sigma) were dissolved in PBS. Stocks of JAK inhibitor 1
(Santa Cruz Biotech, CA), Bayer 11–7085 (Santa Cruz Biotech, CA),
MCC950 (inh-mcc, Invivogen) and Ac-YVAD-cmK (inh-yvad,
Invivogen) were dissolved in DMSO. Antibodies against phospho-
STAT1 (Ser727) (#9177), STAT1 (#9172), MDA5 (D74E4, #5321) and
IRF1 (D5E4, #8478), were purchased from Cell Signaling Technology.
GBP2 antibody (11854-1-AP) was purchased from Proteintech. Rabbit
polyclonal antisera to MNV NS1-2 (Baker, 2012) was kindly provided
by Prof. Vernon K. Ward (School of Biomedical Sciences, University of
Otago, New Zealand). β-actin antibody (#sc-47778) was purchased
from Santa Cruz Biotechnology. IRDye® 800CW-conjugated goat anti-
rabbit and goat anti-mouse IgGs (Li-Cor Bioscience, Lincoln, USA) were
used as secondary antibodies, as appropriate.
2.2. Cell culture and viruses
RAW264.7 and J774A.1 cells were cultured in Dulbecco's modified
Eagle's medium (DMEM; Lonza Verviers, Belgium) supplemented with
10% (vol/vol) heat-inactivated fetal calf serum (FCS; Hyclone, Logan,
UT, USA), 100 μg/mL of streptomycin, and 100 IU/mL of penicillin.
Human Huh7 hepatocellular carcinoma cells harboring a genotype 1
HuNV replicon (HG23) were kindly provided by Dr. Kyeong-Ok Chang
(Kansas State University) (Chang et al., 2006). A neomycin resistant
gene was engineered into ORF2, conferring HG23 resistance to neo-
mycin. Gentamicin (G418; Gibco) was added to HG23 culture medium
at 1.5 mg/mL for selection before experimentation. Mouse embryonic
fibroblast cells (MEFs) (WT, NF-κB−/− and IRF3/7−/−) were kindly
provided by Dr. Sanna M. Mäkelä (National Institute for Health and
Welfare Viral Infections Unit, Helsinki, Finland) with the permission of
Dr. Michael J. Gale and Dr. A. Hoffmann (Mäkelä et al., 2015). Wild-
type (WT) MEFs and MEFs from STAT1−/− mice were generously
provided by Prof. Andrea Kröger (Helmholtz Centre for Infection Re-
search) (Nandakumar et al., 2013).
MNV-1 (murine norovirus strain MNV-1.CW1) was produced by
inoculating the virus (kindly provided by Prof. Herbert Virgin,
Department of Pathology and Immunology, Washington University
School of Medicine) into RAW264.7 cells (Wobus et al., 2004). The
MNV-1 cultures were purified, aliquoted, and stored at −80 °C for all
subsequent experiments. The MNV-1 stock was quantified three in-
dependent times by the 50% tissue culture infective dose (TCID50).
2.3. TCID50
MNV-1 was quantified by TCID50 assay (Hwang et al., 2014).
Briefly, 10-fold dilutions of MNV-1 were inoculated into
RAW264.7 cells grown in 96-well tissue culture plate at 1000 cells/
well. The plate was incubated at 37 °C for another 5 days, followed by
observing the cytopathic effect (CPE) of each well under a light scope.
The TCID50 was calculated by using the Reed-Muench method.
2.4. MNV-1 infection in macrophages
To determine whether MNV-1 infection could activate the in-
flammasome, RAW264.7 (1 × 105 cells/well) and J774A.1
(1 × 105 cells/well) cells were plated at 12-well plate and were rested
for 24 h at 37 °C. Cells were then either left uninfected or infected with
MNV-1 at indicated multiplicity of infection (MOI) for 1 h at 37 °C. The
MNV-1 inoculum was removed and the cells were washed three times
with phosphate-buffered saline (PBS), and fresh medium was added
back onto cells. LPS and ATP treated cells were set as positive control.
Total RNA and cell supernatant samples were prepared at indicated
time and stored at −80 °C before use.
For MNV-1 antiviral assay, RAW264.7 and J774A.1 cells were either
left untreated or treated with LPS, IFN-γ or combination with indicated
compounds for 6 h before inoculation with MNV-1 at 1 MOI. After 1 h
inoculation, the cells were washed with PBS for three times to remove
the residual viruses, and control medium or medium supplemented
with LPS or mouse IFN-γ was added back onto cells. After 24 h of in-
fection, total RNA, protein and supernatant samples were collected
from the cells for further analysis.
2.5. HuNV antiviral assay
Twenty-four hours before experimentation, HG23 cells were cul-
tured in the medium without gentamicin. HG23 cells were seeded into
48-well tissue culture plates (2.5 × 104 cells per well), treated with
different concentrations of LPS or human IFN-α. After 48 h of treat-
ment, total RNA was extracted from cells, and HuNV replication was
determined by qRT-PCR analysis.
2.6. Enzyme-linked immunosorbent assay (ELISA)
Supernatant was analyzed for cytokine IL-1β secretion by an ELISA
kit (KMC0012; Invitrogen) according to manufacturer's instructions.
The absorbance was measured at 450 nm in an automatic microplate
reader. Results were calculated based on a standard curve.
2.7. Quantitative real-time polymerase chain reaction
Total RNA was isolated with a Macherey NucleoSpin RNA II Kit
(Bioke, Leiden, The Netherlands) and quantified with a Nanodrop ND-
1000 (Wilmington, DE, USA). During RNA isolation, DNase was added
to remove genomic DNA according to the manufacturer's instructions.
cDNA was synthesized from 500 ng of RNA using a cDNA synthesis kit
(TaKaRa Bio, Inc., Shiga, Japan). The cDNA of all targeted genes
transcript were quantified by SYBR-Green-based (Applied Biosystems)
real-time PCR on the StepOnePlus™ System (Thermo Fisher Scientific
Life Sciences) according to the manufacturer's instructions. Human
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and murine
GAPDH genes were used as reference genes to normalize gene expres-
sion. The relative expression of targeted gene was calculated as 2−ΔΔCT,
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where ΔΔCT = ΔCTsample - ΔCTcontrol (ΔCT = CT[targeted gene] -
CT[GAPDH]). All primer sequences are listed in Supplementary Table 1
and Table 2.
2.8. Western blotting
Cultured cells were lysed in Laemmli sample buffer containing
0.1 M DTT and heated 5 min at 95 °C, then loaded onto a 10% sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel,
then proteins were electrophoretically transferred onto a poly-
vinylidene difluoride (PVDF) membrane (pore size, 0.45 μM;
Invitrogen) for 2 h with an electric current of 250 mA. Subsequently,
the membrane was blocked with a mixture of 2.5 mL blocking buffer
(Odyssey) and 2.5 mL PBS containing 0.05% Tween 20 for 1 h, followed
by overnight incubation with primary antibodies (1:1000) at 4 °C. The
membrane was washed 3 times and then incubated with IRDye-con-
jugated secondary antibody (1:5000) for 1 h. After washing 3 times,
protein bands were detected with the Odyssey 3.0 Infrared Imaging
System (Li-Cor Biosciences).
2.9. MTT assay
Cells were seeded into 96-well tissue culture plates and cell viability
was assessed by adding 10 mM 3-(4,5-dimethyl-2-thiazolyl)-2,5-di-
phenyl-2H-tetrazolium bromide (MTT) (Sigma, Zwijndrecht, the
Netherlands). After 3 h, the medium was replaced with 100 μL of DMSO
and was incubated at 37 °C for another 50 min. The absorbance at
490 nm was recorded on the microplate absorbance reader (Bio-Rad,
CA, USA).
2.10. Statistical analysis
Data are presented as the mean ± SEM. Comparisons between
groups were performed with Mann-Whitney test using GraphPad Prism
5.0 (GraphPad Software Inc., La Jolla, CA, USA). Differences were
considered significant at a P value less than 0.05.
3. Results
3.1. MNV-1 infection did not induce the release of mature IL-1β, but
increased its mRNA expression, which was further augmented by inhibition
of IFN pathway in macrophages
To investigate whether MNV-1 can activate inflammasome,
J774A.1 cells were used because of its permissiveness for MNV-1 in-
fection and competence in inflammasome activation (Hirano et al.,
2017; Wobus et al., 2004). We first determined the expression of IL-1β
and IL-18 as markers of inflammasome activation in J774A.1 cells
treated with LPS (the component in the outer membrane of gram-ne-
gative bacteria) and ATP, the potent activators for inflammasome ac-
tivation. We found that under stimulation by LPS and ATP, the mRNA
and protein levels of IL-1β were significantly increased (Fig. 1A–C), and
IL-18 mRNA level was moderately elevated (Fig. 1A). Although the IL-
1β mRNA level was modestly elevated in MNV-1 infected J774A.1 cells
(Fig. 1B), no significant differences in IL-1β protein level were observed
in the supernatant of these cells (Fig. 1C). We confirmed active viral
infection by detecting the viral NS1/2 protein in J774A.1 cells
(Fig. 1D). In another macrophage cell line RAW264.7 cells, the IL-1β
and IL-18 mRNA levels were hardly changed upon MNV-1 infection
(Supplementary Fig. 1). However, treatment with LPS and ATP also
failed to induce the expression of these genes (Supplementary Figs. 1A
and 1B), indicating possible defects of the inflammasome machinery in
RAW264.7 cells, which is consistent with a previous study (He et al.,
2015).
We next investigated whether MNV-1 infection has a role in LPS-
induced IL-1β transcription. As expected, the IL-1β mRNA level was
further increased in MNV-1 infected J774A.1 cells by LPS and ATP
stimulation (Fig. 1E), and this effect was also observed in LPS-pre-
treated cells (Fig. 1F). A recent study reported that MNV infection sti-
mulated IL-1β RNA transcription and protein release in STAT1 deficient
BMDMs (Dubois et al., 2019). Thus, we blocked the JAK-STAT pathway
by using JAK-STAT inhibitor (JAK inhibitor 1), and found that inhibi-
tion of JAK-STAT pathway attenuated MNV-1 induced ISG transcription
(Fig. 1G), but increased MNV-1 RNA level (Fig. 1H) and viral infection-
induced IL-1β mRNA transcription (Fig. 1I), which is in accordance
with the recent study (Dubois et al., 2019).
3.2. LPS potently inhibits MNV-1 replication largely independent of
inflammasome
Norovirus cohabits with bacteria in the intestine. Co-infection of
MNV and bacteria in macrophages has been reported to reduce the viral
load (Agnihothram et al., 2015; Li et al., 2016). Thus, we further in-
vestigated the direct effects of bacteria-derived LPS on MNV-1 re-
plication, and found that treatment with LPS potently inhibits viral
replication in J774A.1 cells (Fig. 2A and B). However, this inhibitory
effect on MNV-1 is only partially reversed by pharmacological in-
flammasome inhibitors MCC950 and YVAD-cmk, which did not affect
viral replication (Fig. 2A and B) but decreased the release of mature IL-
1β triggered by LPS and ATP stimulation in J774A.1 cells (Fig. 2C).
We next evaluated the anti-MNV effect of LPS in RAW264.7 cells,
which are incompetent of inflammasome activation (He et al., 2015).
IFN-γ was used as a control. Pre-treatment with LPS potently inhibited
viral RNA and NS1-2 protein levels in a dose-dependently manner
(Fig. 2D). Similar effects were observed when cells were first infected
with MNV-1 then subjected to treatment with LPS (Fig. 2E). Moreover,
the viral titers were also decreased by LPS and IFN-γ pre-treatment
(Fig. 2F).
These results urged us to investigate the antiviral effect of LPS on
HuNV replication by using the Huh7-based HuNV replicon cells
(HG23). After two days of treatment, LPS failed to but human IFN-α
effectively restricted HuNV replication without triggering major cyto-
toxicities (Fig. 3A). It is widely recognized that IFNs exert antiviral
effects via induction of the transcription of ISGs through JAK-STAT
signaling pathway. We further revealed that expression of type I IFNs
(IFN-α and IFN-β) were not significantly induced by both LPS and IFN-
α (Fig. 3B and C). However, IFN-α but not LPS triggered the expression
and phosphorylation of STAT1 (Fig. 3D), and induction of ISGs in-
cluding ISG15, IFIT1 and MX1 in HG23 cells (Fig. 3E). This is consistent
with previous findings that hepatic epithelia cells do not respond to LPS
stimulation (MacParland et al., 2016). This previous study also showed
that LPS suppresses IFN response in hepatocytes by upregulating ubi-
quitin-like protease 18 (USP18) expression, a negative regulator of type
I IFN signaling (MacParland et al., 2016). However, LPS stimulation did
not affect USP18 gene transcription in our study (Fig. 3F).
These results have demonstrated that LPS potently inhibits MNV
replication in macrophages, but has no significant effect on HuNV re-
plication in HG23 cells. This is probably related to the intrinsic property
that epithelial HG23 cells are nonresponsive to LPS stimulation.
3.3. LPS stimulates the transcription of IFN-β and a wide range of ISGs
Given the dispensability of inflammasome in anti-MNV activity of
LPS, we explored other possible mechanisms. It is generally recognized
that LPS stimulation of macrophages induces production of many cy-
tokines and inflammatory mediators including IRF-1, IL-6 and IFNs
(Beutler and Rietschel, 2003; Guha and Mackman, 2001). We found
that LPS stimulated the expression of the viral RNA sensor MDA5 in
RAW264.7 and J774A.1 cells (Fig. 4A and B), and the increased tran-
scription of IFN-β in both cell lines (Fig. 4C and D), respectively. ISGs
are the ultimate antiviral effectors induced by IFNs through the JAK-
STAT pathway. We found the activation of JAK-STAT pathway by
P. Yu, et al. Virology 546 (2020) 109–121
111
(caption on next page)
P. Yu, et al. Virology 546 (2020) 109–121
112
detecting the increased expression of STAT1 at both the protein (Fig. 4A
and B) and transcriptional levels (Fig. 4E and F), respectively. More-
over, the transcription of a wide range of ISGs was also stimulated by
LPS (Fig. 4E and F), and IFN-γ treatment also induced the transcription
of many ISGs in both cell lines (Supplementary Fig. 2). The induction of
several important genes were further confirmed by immunoblotting
(Fig. 4A and B).
3.4. NF-ĸB signaling is important for LPS-induced IFN-β and ISG
transcription
It has been reported that recognition of LPS by TLR4 activates
downstream transcription factors NF-ĸB, leading to the transcription of
IFNs and ISGs (Moynagh, 2005). Thus, we further investigated whether
NF-ĸB signaling is involved in LPS-induced IFN-β and ISG transcription
in macrophages. Treatment with Bay 11–7085, a pharmacological in-
hibitor of NF-ĸB activation, largely inhibits LPS-triggered transcription
of IFN-β (Fig. 5A and C) and most of the ISGs (Fig. 5B and D) in both
macrophage cell lines. Moreover, this inhibitor also attenuated LPS-
induced expression and phosphorylation of STAT1, as well as ISG ex-
pression such as IRF1 and GBP2 (Fig. 5E and F). Similarly, some ISGs
induced by IFN-γ were also affected by Bay 11–7085 treatment in both
cell lines (Supplementary Fig. 3).
To further determine the essential role of NF-ĸB pathway in LPS-
induced ISG expression, wild-type (WT) and NF-ĸB deficient (NF-ĸB−/
−) MEFs were used. In NF-ĸB−/− but not the WT cells, LPS failed to
induce the transcription of IFN-β (Fig. 5G). A similar ISG induction
pattern was also observed in NF-ĸB−/− cells. All of the genes detected
such as IRF1, ISG15, MX1 and GBP2 were significantly induced by LPS
in WT cells but not in NF-ĸB−/− cells (Fig. 5H). Moreover, transcription
of some ISGs induced by IFN-γ were largely decreased in NF-ĸB−/−
cells (Supplementary Fig. 4A). Taken together, these findings revealed
that NF-ĸB pathway is important for LPS-induced IFN-β and ISG tran-
scription.
3.5. IRF3 and IRF7 are important for LPS-induced IFN-β and ISG
transcription
LPS as the ligand activates TLR4, which in turn phosphorylates
downstream IRF3 and IRF7, leading to their nuclear translocation and
induction of type I IFN genes and co-stimulatory molecules (Moynagh,
2005). Moreover, IRF3 and IRF7 have been reported to play an im-
portant role in controlling MNV-1 replication (Thackray et al., 2012).
Thus, by using WT and IRF3/7 deficient (IRF3/7−/−) MEFs, we found
that IFN-β was not induced by LPS in IRF3/7−/− cells (Fig. 6A).
Moreover, the detected genes induced by LPS in WT cells were reduced
in IRF3/7−/− cells (Fig. 6B). Compared to the WT cells, transcription of
ISG15, ISG20, MX1 and IFIT1 appeared to be unchanged, while tran-
scription of other ISGs such as IRF1, MX2, GBP2 and GBP5 induced by
IFN-γ was decreased in IRF3/7−/− cells (Supplementary Fig. 4B). These
results suggested that IRF3 and IRF7 are also important for LPS-induced
IFN-β and ISG transcription.
3.6. LPS induces ISG transcription largely through activation of JAK-STAT
pathway
The JAK-STAT signaling pathway has been shown to be essential for
LPS-mediated gene expression in macrophages (Kovarik et al., 1998;
Ohmori and Hamilton, 2001). Consistent with these results, we also
observed that LPS induced the expression and phosphorylation of
STAT1 in both RAW264.7 and J774A.1 cells, respectively (Fig. 7C and
D). To determine whether ISG induction by LPS is through the activa-
tion of STAT1, we used JAK-STAT inhibitor to pharmacologically block
the JAK-STAT pathway. We found that JAK inhibitor 1 partially
blocked LPS induced transcription of IFN-β in both RAW264.7 and
J774A.1 cells (Fig. 7A and B), while both the expression and phos-
phorylation of STAT1 triggered by LPS and IFN-γ were largely atte-
nuated by this inhibitor (Fig. 7C and D). Next, we tested the mRNA level
of some ISGs in LPS-stimulated macrophages treated with JAK inhibitor
1, and found that most of the LPS inducible genes were affected by JAK
inhibitor 1 (Fig. 7E and F), without triggering major cytotoxicities
(Supplementary Fig. 5D). In addition, the mRNA levels of these genes
induced by IFN-γ were largely diminished by this inhibitor
(Supplementary Figs. 5A and 5B).
To further confirm the ISG induction ability of LPS is partially de-
pendent on the JAK-STAT pathway, we performed experiments with
MEFs from WT and STAT1−/− mice to examine the effect of STAT1 on
ISG expression (Fig. 7G and H). We found that the abundance of de-
tected ISGs triggered by LPS were also largely decreased in STAT1−/−
cells compared to those in WT cells (Fig. 7I). As a control, the tran-
scription of IFN-γ induced ISGs was significantly blocked in STAT1−/−
cells (Supplementary Fig. 5C). Together, these results demonstrated
that LPS activates ISG transcription largely through the activation of the
JAK-STAT pathway.
3.7. The NF-ĸB cascade contributes to LPS-mediated inhibition of MNV-1
replication partially through the JAK-STAT pathway
In respect to the anti-MNV effects of LPS, we found that Bay
11–7085, the NF-ĸB signaling inhibitor, partially reversed LPS and IFN-
γ-mediated antiviral response against MNV-1 infection in
RAW264.7 cells (Fig. 8A and E). Similar results were also observed in
J774A.1 cells (Fig. 8B). Interestingly, the inhibitor alone enhanced viral
replication (Fig. 8A, B and 8E), suggesting a basal defense mechanism
of NF-ĸB signaling against MNV-1 infection. Moreover, we also de-
termined the role of JAK-STAT pathway in LPS-mediated antiviral ac-
tivity and found that the anti-MNV activity of LPS was only moderately
reversed, whereas the anti-MNV effect of IFN-γ was largely abolished by
JAK inhibitor 1 (Fig. 8C–E). Together, these results have demonstrated
that NF-ĸB cascade contributes to LPS-mediated control of MNV-1 re-
plication partially through the JAK-STAT pathway.
4. Discussion
Innate immune response provides the first line of defense against
viral infection. Studies have revealed that compared to wild-type mice,
mice lacking either type I and type II IFN receptors or STAT1 have
higher titers and succumb to lethal MNV infection (Karst et al., 2003;
Thackray et al., 2012), indicating the importance of IFNs in controlling
Fig. 1. MNV-1 infection did not induce the release of mature IL-1β, but increased its mRNA level in macrophages. J774A.1 cells were untreated or treated
with LPS (400 ng/μl) for 4 h and then ATP (5 mM) for 40 min, or left uninfected or infected with MNV-1 (MOI 1) for 24 h, and total RNA and cell culture supernatants
were collected. mRNA levels of IL-1β (A and B) (n = 6) and IL-18 (A) (n = 6), and protein level of IL-1β (C) (n = 4) were analyzed by qRT-PCR and ELISA,
respectively. Western blotting (D) was used to analyze the viral infection in J774A.1 cells at indicated times. (E) J774A.1 cells were uninfected or infected with MNV-
1 (MOI 1) for 20 h, then treated with LPS (400 ng/μl) for 4 h and ATP (5 mM) for 40 min mRNA level of IL-1β and cytotoxicity were analyzed by qRT-PCR (n = 8). (F)
J774A.1 cells were untreated or treated with LPS (400 ng/μl) for 4 h then uninfected or infected with MNV-1 (MOI 1) for 24 h mRNA level of IL-1β and cytotoxicity
were analyzed by qRT-PCR (n = 8). J774A.1 cells were untreated or treated with JAK inhibitor 1 (10 μM) for 6 h then uninfected or infected with MNV-1 (MOI 1) for
24 h mRNA levels of indicated genes (G) (n = 6), MNV-1 RNA (H) (n = 6) and IL-1β mRNA (I) (n = 6) were analyzed by qRT-PCR, respectively. Data were
normalized to the untreated control (CTR, set as 1). *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant. β-actin was used as a loading control.
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Fig. 2. LPS potently inhibits MNV-1 replication largely independent of inflammasome. J774A.1 cells were treated with LPS (400 ng/μl), MCC950 (5 μM),
YVAD-cmk (5 μM), or combination for 6 h, then infected with MNV-1 (MOI 1) for 24 h. (A) The viral RNA, NS1/2 protein and cytotoxicity were analyzed by qRT-PCR
(n = 6), western bloting, and MTT (n = 16) assays, respectively. (B) The viral titers were also analyzed by TCID50 assay (n = 4–6). (C) J774A.1 cells were untreated
or treated with LPS (400 ng/μl), MCC950 (5 μM), YVAD-cmk (5 μM), or combination for 4 h and then ATP (5 mM) for 40 min. The cell culture supernatants were
collected and used for analysis of IL-1β by ELISA assay (n = 6). (D) RAW264.7 cells were untreated or treated with different concentrations of LPS as indicated, or
IFN-γ (100 U/ml) for 6 h, then infected with MNV-1 (MOI 1) for 24 h. The viral RNA, NS1/2 protein and cytotoxicity were analyzed by qRT-PCR (n = 6), western
blotting and MTT (n = 8) assay, respectively. (E) RAW264.7 cells were infected with MNV-1 (MOI 1) for 1 h, then added fresh medium or medium supplemented
with LPS at indicated concentrations or IFN-γ (100 U/ml) for 24 h. The viral RNA, NS1/2 protein and cytotoxicity were analyzed by qRT-PCR (n = 3 independent
experiments with 2–3 replicates each), western blotting and MTT (n = 8) assays, respectively. (F) RAW264.7 cells were untreated or treated with different con-
centrations of LPS as indicated, or IFN-γ (100 U/ml) for 6 h, then infected with MNV-1 (MOI 1) for 24 h. The viral titers were analyzed by TCID50 assay (n = 6). Data
were normalized to the untreated control (CTR, set as 1). *P < 0.05; **P < 0.01; ns, not significant. ND, not determined. β-actin was used as a loading control.
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norovirus infection. Besides IFNs, inflammasome signaling also has a
central role in innate immune response against viral infections (Zhu
et al., 2017). Previous evidence indicated the potential role of in-
flammasome in norovirus replication (Wang et al., 2015). However, in
this study, MNV-1 infection failed to adequately activate inflammasome
activation in macrophages, although moderate activation of IL-1β
transcription was observed in J774A.1 cells. Similar results have been
reported that MNV failed to secrete IL-1β in WT BMDMs, but presented
caspase-1 processing ability (Dubois et al., 2019). In inflammasome-
incompetent RAW264.7 cells, which lack the expression of ASC, one of
the components for inflammasome complex formation (He et al., 2015),
MNV-1 infection appeared not to affect IL-1β transcription. A recent
study reported that MNV infection induced mature IL-1β secretion in
STAT1 deficient BMDMs (Dubois et al., 2019). Compared to MNV-1
infection alone, we also observed the increased IL-1β transcription level
induced by MNV-1 with JAK-STAT pathway inhibition. Studies have
reported the crosstalk between IFN response and inflammasome acti-
vation (Kopitar-Jerala, 2017). Here we revealed that inhibition of JAK-
STAT pathway reduced MNV-1 infection triggered IFN response, but
increased MNV-induced IL-1β transcription. Moreover, decreased IFN
response by inhibition of JAK-STAT pathway resulted in increased viral
replication, which might further contribute to the upregulation of IL-1β
transcription. Thus, whether there is a potential crosstalk between IFN
response and inflammasome activation in response to MNV infection
needs to be further studied.
Norovirus and bacteria are cohabitants of the intestine. Gram-ne-
gative bacteria produce a large amount of LPS, which are naturally
potent activators of inflammasome. It has been reported that hepatitis B
virus (HBV) infection inhibits LPS-induced inflammasome activation,
although HBV alone does not activate inflammasome (Yu et al., 2017).
Moreover, studies have revealed that MNV infection can induced ma-
ture IL-1β release in primed BMDMs with TLR2 agonist (Pam3CSK4)
and TLR4 agonist (LPS) (Dubois et al., 2019), and here we found that
MNV-1 augmented LPS-induced IL-1β transcription. Interestingly, we
observed that LPS inhibited MNV-1 replication, but this inhibitory ef-
fect was only slightly reversed by inflammasome inhibitors, suggesting
Fig. 3. HuNV replication is not affected by LPS in the replicon model. (A) HG23 cells were untreated or treated with different concentrations of LPS as indicated,
or IFN-α (200 IU/ml). After 2 days of treatment the antiviral activities and cytotoxicity were measured by qRT-PCR (n = 6) and MTT assay (n = 16), respectively.
qRT-PCR analysis (n = 4) of mRNA levels of IFN-α (B), IFN-β (C), STAT1 (D upper panel), ISGs (E), USP18 (F) and western blotting analysis of STAT1 expression and
phosphorylation (D lower panel) in HG23 cells untreated or treated with LPS (100 ng/ml) or IFN-α (200 IU/ml). Data were normalized to the untreated control (CTR,
set as 1). *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant. β-actin was used as a loading control.
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additional mechanisms contributing to the anti-MNV activity of LPS.
These inhibitors might have a negative role on LPS-triggered expression
of inflammatory factors, which could aid to LPS-mediated antiviral
response against MNV infection to some extent. However, we do not
exclude that there could be more active interactions of norovirus with
inflammasome in other cell types, which deserve to be further in-
vestigated. Moreover, blocking NLRP3 inflammasome activation has
been reported to reduce MNV-induced immunopathology in STAT1-
deficient mice (Dubois et al., 2019). In addition, we found that in-
flammasome inhibitors alone appear not to affect the viral replication,
Fig. 4. LPS stimulates the transcription of a wide range of ISGs. Western blotting analysis of ISG protein levels in RAW264.7 cells (A) and J774A.1 cells (B)
untreated or treated with LPS (100 ng/ml) or IFN-γ (100 U/ml) for 6 h qRT-PCR analysis of mRNA level of IFNs (C and D) (n = 6) and ISGs (E and F) (n = 4) in
RAW264.7 cells and J774A.1 cells that untreated or treated with LPS (100 ng/ml) for 6 h, respectively. Data were normalized to the untreated control (CTR, set as 1).
*P < 0.05; **P < 0.01; ns, not significant. β-actin was used as a loading control.
P. Yu, et al. Virology 546 (2020) 109–121
116
Fig. 5. NF-ĸB signaling is important for LPS-
induced IFN-β and ISG transcription. Cells
were untreated or treated with LPS (100 ng/
ml), Bay 11–7085 (5 μM) or combination for
6 h qRT-PCR analysis of IFN-β (A) and ISG (B)
mRNA levels in RAW264.7 cells (n = 6). qRT-
PCR analysis of IFN-β (C) and ISG (D) mRNA
levels in J774A.1 cells (n = 6). Western blot-
ting analysis of STAT1 expression and phos-
phorylation, and expression of IRF1 and GBP2
in RAW264.7 cells (E) and J774A.1 cells (F)
untreated or treated with LPS (100 ng/ml),
IFN-γ (100 U/ml), Bay 11–7085 (5 μM) or
combination for 6 h qRT-PCR analysis of
mRNA levels of IFN-β (G) (n = 6) and ISGs (H)
(n = 6) in WT and NF-ĸB−/−MEFs untreated
or treated with LPS (100 ng/ml) for 6 h. Data
in (A, B, C, D and G) were normalized to the
untreated control (CTR, set as 1). Data in (H)
were normalized to untreated WT and NF-
ĸB−/− MEFs, respectively (both set as 1).
*P < 0.05; **P < 0.01. β-actin was used as a
loading control.
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and similar results were also demonstrated that MNV replication rates
were not affected in WT or NLRP3−/− BMDMs (Dubois et al., 2019).
As a type of PRRs, TLRs are responsible for the recognition of in-
fectious agents leading to activation of innate immune response
(Hertzog et al., 2003). It has been reported that TLR7 activation by its
agonists displays potent antiviral effects against norovirus infection by
stimulating innate immune response genes (Tuipulotu et al., 2018). As a
ligand of TLR4, LPS can activate transcription factors NF-ĸB and IRFs,
leading to the activation of IFN signaling (Moynagh, 2005). IFNs are
central to the innate control of MNV infection (Changotra et al., 2009;
Hwang et al., 2012; Nice et al., 2015). Here we found that LPS potently
induces IFN-β transcription, and pharmacological inhibition of NF-ĸB
signaling significantly blunts LPS-triggered IFN-β transcription, which
is further confirmed in NF-ĸB deficient cells. Moreover, transcription
factors IRF3 and IRF7 can regulate IFN-mediated inhibition of MNV-1
replication (Thackray et al., 2012), and we found in this study that IFN-
β transcription induced by LPS is largely attenuated in IRF3 and IRF7
deficient cells.
ISGs are regarded as the ultimate antiviral effectors, and several
ISGs such as IRF1, ISG15 and GBP2 have been reported to mediate the
anti-norovirus effect of IFN (Biering et al., 2017; Maloney et al., 2012;
Orchard et al., 2019; Rodriguez et al., 2014). In this study, we found
that LPS also potently triggers ISG expression via the transcription
factors including NF-ĸB, IRF3 and IRF7. Moreover, blocking NF-ĸB
signaling attenuates LPS and IFN-γ mediated control of MNV-1 re-
plication. JAK-STAT pathway is essential for IFN-induced ISG expres-
sion (Ohmori and Hamilton, 2001; Shuai and Liu, 2003) and host innate
immunity against MNV infection (Karst et al., 2003). We revealed that
induction of ISGs triggered by LPS or IFN-γ are dramatically decreased
by inhibition of the JAK-STAT pathway, which also largely abolishes
IFN-γ mediated inhibition for MNV-1 replication. However, blocking
this pathway partially reverses LPS-mediated anti-MNV ability. This
indicates that LPS-triggered ISGs are partially responsible for its anti-
viral response against MNV-1 infection in macrophages, and other un-
known antiviral mechanisms mediated by LPS may be involved. Fur-
thermore, the non-canonical mechanisms regulating ISG transcription
have been reported (Wang et al., 2017). Induction of ISGs via NF-kB
cascade might do not require JAK-STAT signaling, and this may account
for the partial restoration of MNV replication by the inhibitors.
Accumulating evidences have demonstrated the interaction between
gut microbiota and intestinal viruses including norovirus (Baldridge
et al., 2015; Jones et al., 2014; Miura et al., 2013). Several mechanisms
have been reported on how intestinal viruses interact with bacteria. On
one hand, gut microbiota has been revealed to facilitate MNV replica-
tion through an antagonistic mechanism to IFN-lambda in the intestine
(Baldridge et al., 2015), and prompt HuNV infection in intestinal B cells
(Jones et al., 2014). Bacterial component of the enteric microbiome
plays an essential role in the establishment of viral persistent infection.
For instance, histo-blood group antigen (HBGA)-like substances im-
prove virion stability and protect HuNV from acute heat stress (Li et al.,
2015), and infection of B cells (Jones et al., 2014). It has been also
reported that LPS binding promotes viral infectivity by enhancing
virion stability and cell attachment (Kuss et al., 2011; Robinson et al.,
2014), but fails to enhance HuNV infection of B cells in vitro (Jones
et al., 2014), and inhibits MNV-1 replication in macrophages in this
study. On the other hand, previous studies have presented the antag-
onistic mechanisms that Enterobacter cloacae, a member of enteric
commensal bacteria specifically binds HuNV, and inhibits virus in-
fectivity in gnotobiotic pigs by enhancing the gut immunity (Lei et al.,
2016). In addition, the microbiota-host interaction can also modulate
the production of immune system molecules, resulting in anti-MNV
effects. Thus, the interactions between intestinal bacteria and viruses
collectively modulate the infection outcomes.
In summary, our study demonstrates that MNV-1 moderately trig-
gers IL-1β transcription, and is augmented by inhibition of IFN pathway
in macrophages. Importantly, LPS potently inhibits MNV-1 replication,
might through inflammasome to some extent but mainly via the NF-ĸB
cascade. Activation of NF-ĸB by LPS drives the expression of IFN-β
through IRF3 and IRF7. This activates the downstream antiviral ISGs
via the JAK-STAT pathway. Moreover, inhibition of NF-ĸB and JAK-
STAT signaling partially reversed the anti-MNV activity of LPS, sug-
gesting additional antiviral mechanisms activated by NF-ĸB, which
need to be further studied. Our study has revealed new insight in virus-
cell interactions, and may provide rationale for new therapeutic de-
velopment against norovirus infection.
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